Global Therapeutic Drug Monitoring Market Key Player, Trends, Analysis And Forecast

According to the new market research report “Therapeutic Drug Monitoring Market by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User – Global Forecast to 2025″, published by MarketsandMarkets™, the TDM Market is projected to reach USD 2.0 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.9% from 2020 to 2025.

Driver: Increasing preference for precision medicine;

Precision medicine is an evolving approach for disease treatment and prevention that considers individual variability in genes, environments, and lifestyles. Precision medicine involves selecting drugs wholly tailored to a patient based on disease condition and history. Although this practice is expanding into all disease areas, oncology has seen the most progress.

Currently, cancer patients are being provided treatment through combination drugs, based on studies conducted on the patient’s parameters such as systems biology, analysis of the tumor, and gene expression data in the absence and presence of pharmacological perturbation. This approach, which is currently being tested in various settings, aims to revolutionize pharmacotherapy in oncology and other disease areas. TDM can be of immense value to advance this novel way of treating patients.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443

Immunoassays is expected to hold the largest share of the TDM Market in 2020

Based on technology, segmented into immunoassays and chromatography-MS. In 2019, immunoassays segment accounted for the largest market share, due to the increasing incidence of chronic and infectious diseases and technological innovation.

Antiepileptic drugs is expected to hold the largest share of the therapeutic drug monitoring market in 2020

On the basis of class of drug, the market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and other drugs. During 2019, antiepileptic drugs held the largest share among the class of drug due to the high complexity and heterogeneity of epilepsy, lack of biological markers or specific clinical signs aside from the frequency of seizures to assess treatment efficacy or toxicity, and the highly complex pharmacokinetics of these drugs.

Hospital laboratories segment commanded the largest share of the TDM Market in 2019

By end user, the market is segmented into hospital laboratories, commercial & private laboratories, and other end users. Hospital laboratories accounted for the largest share of the market in 2019. The large share of this segment can be attributed to factors such as the availability of advanced healthcare facilities in hospitals and the rising incidences of chronic diseases.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=155350443

North America commanded the largest share of the therapeutic drug monitoring market in 2019.

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America commanded the largest share of the market. Increasing per capita healthcare expenditure and the presence of technologically advanced healthcare infrastructure in the region, coupled with initiatives taken by different government associations, are anticipated to boost the market growth in the region.

The major players operating in this therapeutic drug monitoring market are Abbott Laboratories (U.S.), F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux (France), BÜHLMANN Laboratories (Switzerland), SEKISUI MEDICAL (Japan), Randox Laboratories (Ireland), DiaSystem Scandinavia AB (Sweden), Cambridge Life Sciences Limited (United Kingdom), ARK Diagnostics, Inc. (U.S.), Chromsystems Instruments & Chemicals GmbH (Germany), Grifols (Spain)

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=155350443

Global Dental Syringes Market Trends and Industry Analysis Report 2020

The Technological advancements in dental syringes, growth in geriatric population and government legislations to avoid needlestick injuries are adding to the growth prospects of this market.

Emerging markets (such as India, China, Brazil, and Mexico) offer significant growth opportunities for players operating in the dental syringes market. The growth of the market in these regions can be attributed to factors such as rising geriatric population, rising awareness among healthcare professionals related to needlestick injuries, and ongoing government initiatives to modernize & expand healthcare infrastructure.

Expected Revenue Surge: The Dental Syringes Market is expected to reach USD 126.9 Million, at a CAGR of 5.2% during the forecast period

Objectives of the Study;

• To define, describe, and forecast the global market on the basis of product, type, material, and region
• To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=42523876

Market Segmentation in Detailed:

Based on Product;

Categorized into three segments, namely, non-disposable syringes, disposable syringes, and safety syringes. The non-disposable syringes segment is expected to dominate the dental syringes market in 2016 mainly due to the growing number of endodontic & periodontic procedures across the globe, significant adoption of non-disposable syringes among dental professionals for administering anesthesia, and greater affordability of these products due to their reusable nature.

Based on Type,

Segmented into two segments, namely, aspirating syringes, and non-aspirating syringes. The aspirating syringes segment is expected to dominate the dental syringes market during the forecast period. The prominent market position of the aspirating syringes segment can be primarily attributed to the procedural benefits offered by aspirating syringes over conventional syringes (such as easy syringe handling, minimal operational stress, and better operational control), and longer shelf life of metallic syringes (as compared to conventional plastic syringes).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42523876

Geographically;

Segmented into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. The growth opportunities in the Asia-Pacific region can be attributed to the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population, especially in Japan and China), rising awareness among healthcare professionals related to needlestick injuries, ongoing government initiatives to modernize & expand healthcare infrastructure, and continuous reduction in product prices.

Global Key Leaders:

Septodont (U.S.), 3M Company (U.S.), Dentsply International, Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Vista Dental Products (U.S.), Power Dental USA, Inc. (U.S.), 4tek S.r.l (Italy), A. Titan Instrument Inc. (U.S.), and Delmaks Surgico (Pakistan) were some of the key players operating in the dental syringes market.

Back-end Revenue Cycle Management Market Size, Share on Global Analysis Report 2019-2023

The Factors such as the growing importance of denials management, increasing patient volume, process improvements in healthcare organizations, and declining reimbursement rates are driving the growth of the market. However, the high cost of deployment, integration of back-end revenue cycle management solutions, data breaches and loss of confidentiality, and lack of skilled IT professionals in healthcare are expected to limit market growth to a certain extent in the coming years.

According MarketsandMarkets Research – The Back-end Revenue Cycle Management Market is projected to reach USD 10.4 billion, at a CAGR of 5.0%.

Market Dynamics:

Growing importance of denials management;

To reduce costs and maximize profits, insurance companies are increasingly denying claims as well as coverage to patients being treated for chronic or persistent illnesses. This is putting an extra burden on healthcare providers to manage operating costs, and in turn is supporting the adoption of back-end revenue cycle management solutions (with a growing number of healthcare providers focusing on properly analyzing denied claims and appealing them).

Many healthcare providers across the globe still use manual and paper-oriented approaches to manage denials. This results in errors, delayed follow-ups, and miscommunication between healthcare providers and insurance companies. The use of back-end revenue cycle management solutions over manual and paper-oriented approaches can not only help healthcare providers overcome these issues but also help them save significant costs.

Browse 79 market data Tables and 31 Figures spread through 136 Pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=204439794

Services segment to dominate the back-end revenue cycle management market

By product & service, segmented into software and services. The services segment is expected to account for the largest share of the back-end RCM Market in 2018. The large share of this segment can be attributed to the recurring nature of services such as training and development, installation, software upgrades, consulting, and maintenance. However, due to the need for periodic software upgrades, the software segment is expected to witness the highest growth during the forecast period.

cloud-based systems to register the highest CAGR during the forecast period

On the basis of delivery mode, segmented into on-premise and cloud-based systems. The cloud-based segment is expected to register the highest CAGR of the back-end revenue cycle management market during the forecast period. Growth in this segment can be attributed to the comparatively lower capital expenses and operational costs incurred in this model, alongside its scalability, flexibility, and affordability.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=204439794

Geographically, the back-end revenue cycle management market is divided into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share in 2018 owing to factors such as growing HCIT investments in the region and the presence of regulatory mandates. North America is followed by Europe and Asia. The market in Asia is relatively nascent; however, it is projected to be the fastest-growing market during the forecast period.

Athenahealth (US), Cerner Corporation (US), Allscripts Healthcare Solutions, Inc. (US), eClinicalWorks (US), Optum, Inc. (US), McKesson Corporation (US), Conifer Health Solutions (US), GeBBs Healthcare Solutions (US), The SSI Group (US), GE Healthcare (US), nThrive (US), DST Systems (US), Cognizant Technology Solutions (US), and Quest Diagnostics (US) are the key players in the back-end revenue cycle management market.

Medical Supplies Market 2018-2023: Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Medtronic plc (Ireland)

[227 Pages Report] The Global Medical Supplies Market is projected to grow from USD 133.5 billion by 2025 from USD 132.6 billion in 2020, at a CAGR of 4.6%.

Market Size Estimation;

Both top-down and bottom-up approaches were used to estimate and validate the total size of the medical supplies market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

• The key players in the industry and market have been identified through extensive secondary research.
• The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation;

After arriving at the overall medical supplies market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the medical supplies industry.

Browse 126 market data Tables and 45 Figures spread through 227 Pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=64344238

Market Segmentation in Depth:

By type, the medical supplies market is segmented into diagnostic supplies, infusion & injectable supplies, intubation & ventilation supplies, disinfectants, personal protective equipment, sterilization consumables, wound care consumables, dialysis consumables, radiology consumables, catheters, sleep apnea consumables, and other medical supplies. The intubation & ventilation supplies segment is expected to grow at the highest growth rate during the forecast period. The growth of this segment is driven mainly by the rising prevalence of respiratory diseases such as asthma and COPD across the globe.

The applications market is categorized into urology, wound care, radiology, respiratory, infection control, cardiology, IVD, and other applications. The other applications segment held the largest market share in 2019, due to factors such as the increasing number of surgical procedures, rising prevalence of dental diseases, and the increasing focus on adhering to proper waste disposal methods.

Download PDF Brochure: 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64344238

Geographical Analysis in Detailed:

The global medical supplies market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. The increasing incidence of COVID-19 in the US and the implementation of various supportive initiatives by the Canadian Government are the major factors driving the growth of the medical supplies market in North America.

Major Key Players:

The prominent players operating in the global medical supplies market include Medtronic (Ireland), Cardinal Health, Inc. (US), BD (US), Johnson & Johnson (US), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Thermo Fisher Scientific, Inc. (US), Baxter International, Inc. (US), Avanos Medical, Inc. (US), 3M (US), Smith & Nephew (Ireland), ConvaTec Group Plc. (UK), Abbott (US), Cook Medical (US), Merit Medical Systems (US), Stryker (US), Terumo Corporation (Japan), Teleflex Incorporated (US), Fresenius Medical Care AG & Co. KGaA (Germany), and Coloplast Group (Denmark).

Global HIP Replacement Devices Market Trends and Industry Analysis Report 2018

According to the new market research report "Hip Reconstruction Devices Market by Product (Primary Hip Reconstruction Devices (Cemented, Cementless), Partial Hip Reconstruction Devices, Revision Hip Reconstruction Devices, HIP Resurfacing), Geography (Americas, EU-5, Japan, BRIC, South-East Asia, MEA) - Forecast", published by MarketsandMarkets™, is estimated to reach USD 5.9 Billion, at a CAGR of 3.0%

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?
id=76831539

 The government initiative of allocating new funds and development of new policies have reduced the waiting time for hip reconstructions, and increased the number of operations. However, it is difficult to achieve 90% threshold of patients that receive care within the regulated time. The technological advancements in hip reconstruction market, such as newly developed prostheses with improved strength and reliability of joints are reducing the need and cost of revision surgery. The minimally invasive techniques for hip reconstruction surgery will improve the precision and accuracy of surgeons, thus reducing the time of surgery. The emergence of these techniques and other improved surgical tools for the treatment of arthritis is expected to address the rising demand for surgery during the forecast period.

Browse and in-depth TOC on "Hip Reconstruction Devices Market" 
105 - Tables
114 -  Figures 
228 - Pages 

In 2014, the global hip reconstruction devices market was dominated by North America. This market is segmented and forecast on the basis of product, and geography. The product comprises of primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices and hip resurfacing devices.

The primary hip reconstruction devices are subsegmented into cementless and cemented reconstruction device. The market is further segmented and forecast on the basis of major geographies such as North America, Europe, and Asia-Pacific. These major geographies are further sub-segmented into major countries.

The market in North America is growing due to rising pool of arthritis, and favorable reimbursement. The European market is growing due to the technological advancements and is dominated majorly by Zimmer Inc. (U.S.) and Depuy Synthes (U.S.). The Asian market is growing due to growing health awareness among masses, along with increase in the spending capacity of the Indian population. Also, increasing number of population suffering from musculoskeletal disorders (MSD), government initiatives, and rising awareness towards hip reconstruction are propelling the market growth. 

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=76831539

The research study is aimed at identifying emerging trends and opportunities in the global hip reconstruction devices market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global hip reconstruction devices market, on the basis of product, and region.

Antinuclear Antibody Test Market 2019 Segmentation by Regions, Challenges and Scope

The Research report on Antinuclear Antibody Test Market covers key statistics for the upcoming forecast year. This Research Report is a big source for the guidance to business leaders, strategy heads.

The Research Report on Antinuclear Antibody Test Market provides report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the ANA testing market, along with revenue estimates & forecasts and market share analysis.

The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this market.

Download PDF (Antinuclear Antibody Test):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218189007

This research report segments this Antinuclear Antibody Test Market based on products, diseases, techniques, end users, and regions.

In the products market, the assay kits & reagents segment is expected to account for the largest share. This segment is also expected to grow at the highest CAGR during the forecast period due to the growth in the number of reagent rental agreements and the increasing prevalence of autoimmune diseases worldwide.

Antinuclear Antibody Test Market Based on Product;

Based on products, the market is segmented into assay kits & reagents, systems, and software & services. The assay kits & reagents segment is expected to account for the largest share of the global Antinuclear Antibody Test Market. The growth in this segment can majorly be attributed to the growth in the number of reagent rental agreements and the increasing prevalence of autoimmune diseases.

Request Free Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=218189007

Antinuclear Antibody Test Market Based on techniques;

the market is segmented into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market due to the expanding applications of ANA in autoimmune disease Testing and therapeutic drug level monitoring.

Antinuclear Antibody Test Market Based on end user;

The end user segments in the market include clinical laboratories, hospitals, POLs, and other end users. The hospital's segment is expected to account for the largest share of the global Antinuclear Antibody Test Market. Growth in this segment can be attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories, primarily due to easy access to reports and smooth logistics.

Read More in Detailed (Antinuclear Antibody Test Market):

https://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html

Oxygen Therapy Equipment Market Analysis, Segments, Key Players, Drivers, Trends and Forecast

The Oxygen Therapy Equipment Market is expected to reach USD 4.01 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 8.7% from 2017 to 2022.

According to a new market research report “Oxygen Therapy Equipment Market by Product (Oxygen Source (Concentrator, Cylinder), Delivery Devices), Portability (Stationary, Portable), Application (COPD, Asthma, Cystic Fibrosis, Pneumonia), End User (Hospital, Home Care) — Global Forecast to 2022”, published by MarketsandMarkets™.

Browse 148 market data tables and 46 figures spread through 175 pages and in-depth TOC on “Oxygen Therapy Equipment Market”

http://www.marketsandmarkets.com/Market-Reports/oxygen-therapy-equipment-market-118828572.html

Factors driving the growth of this market are the increasing prevalence of respiratory disorders, rapid growth in the geriatric population, prevalence of tobacco smoking, preference towards home-based oxygen therapy, and technological advancements to develop novel products delivering oxygen therapy.

Oxygen source equipment is expected to dominate the market in 2017

On the basis of products, the Oxygen Therapy Equipment Market is segmented into oxygen source equipment and oxygen delivery devices. The oxygen source equipment segment is expected to dominate the global Oxygen Therapy Equipment Market in 2017. The increasing incidence of respiratory disorders and technological advancements to develop smaller, quieter and more effective equipment are key drivers increasing the demand for oxygen source equipment.

Download PDF Brochure:http://www.marketsandmarkets.com/pdfdownload.asp?id=118828572

Stationary oxygen therapy devices are estimated to command the largest market share in 2017

The Oxygen Therapy Equipment Market is segmented by portability into stationary devices and portable devices. In 2017, the stationary devices segment is expected to account for the largest share of the Oxygen Therapy Equipment Market, by portability. Severe complications in patients suffering from respiratory disorders and the increasing proportion of geriatric population across the globe are major drivers for the growth of this segment.

North America to account for the major market share in 2017

Based on region, the Oxygen Therapy Equipment Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to dominate the Oxygen Therapy Equipment Market in 2017 on account of the increasing proportion of the geriatric population, rising number of hospitals, and increasing awareness regarding oxygen therapy.

Talk To Our Research Analysts:http://www.marketsandmarkets.com/speaktoanalyst.asp?id=118828572

Key players in the Oxygen Therapy Equipment Market include Philips Healthcare (Netherlands), Linde Healthcare (Germany), Chart Industries, Inc. (U.S.), Invacare Corporation (U.S.), Becton, Dickinson and Company (U.S.), Smiths Medical (U.S.), Drägerwerk AG & Co. KGaA (Germany), Teleflex Incorporated (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Taiyo Nippon Sanso Corporation (Japan),

Medical Supplies Market Analysis 2018 Globally by Key Manufacturers, Countries, Type, Application and Forecast

The Medical Supplies Market is expected to reach USD 136.63 Billion by 2021 from USD 98.33 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021.

According to a new market research report “Medical Supplies Market by Type (Diagnostic, Dialysis, Wound Care, Inhalation, Infection Control, Infusion, Intubation, PPE), Application (Anesthesia, Radiology, Sterilization) & End User (Hospital, Clinic, Nursing Home) — Global Forecast to 2021” published by MarketsandMarkets.

Browse 150 market data Tables and 61 Figures spread through 225 Pages and in-depth TOC on “Medical Supplies Market”

http://www.marketsandmarkets.com/Market-Reports/medical-supplies-market-64344238.html

This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the global Medical Supplies Market along with the estimates and forecasts of the revenue and market share analysis. The major factors driving the growth of this market are rising geriatric population, increasing incidence of various diseases, and rising number of surgeries.

This report segments the Medical Supplies Market on the basis of type, application, end user, and region. Based on type, the market is segmented into diagnostic supplies, dialysis consumables, wound care consumables, inhalation products, radiology consumables, infection control supplies, infusion products, intubation and ventilation supplies, personal protective equipment (PPE), hypodermic products, sterilization consumables, and other supplies.

Ask for PDF Brochure @http://www.marketsandmarkets.com/pdfdownload.asp?id=64344238

Based on application, the market is segmented into urology, wound care, radiology, anesthesia, sterilization, cardiology, ophthalmology, and other applications. The anesthesia segment is expected to register the highest growth during the forecast period. The high growth in this segment is attributed to the increasing number of surgical procedures being performed across the globe and the rising incidence of respiratory diseases.

Based on end user, the market is segmented into hospitals, clinics, assisted living centers and nursing homes, ambulatory surgery centers (ASCs), and other end users. The hospitals segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing investment in healthcare systems, growing prevalence of HAIs, and high incidence of chronic diseases across the globe.

On the basis of region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asiais projected to be the fastest-growing region in the forecast period, owing to factors such as the rising geriatric population, increasing incidence of various diseases, growing medical tourism industry, and improving healthcare infrastructure.

Speak to Our Experts @http://www.marketsandmarkets.com/speaktoanalyst.asp?id=64344238

The key players in the Medical Supplies Market include Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), Cardinal Health, Inc. (U.S.), Halyard Health, Inc. (U.S.), Johnson & Johnson (U.S.), Thermo Fisher Scientific Inc. (U.S.), Boston Scientific Corporation (U.S.), Baxter International Inc. (U.S.), and 3M Company (U.S.).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Global Bone Growth Stimulator Market Size, Market Growth Projection to 2022

[153 Pages Report] The global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion by 2022 from 1.03 billion at a CAGR of 5.4% during the forecast period.

The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market.

Don’t miss out on business opportunities in Bone Growth Stimulator Market.

Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.

Market Dynamics

Drivers

• Growing patient preference for noninvasive and minimally invasive surgical treatments
• Increasing target patient population
• Procedural benefits offered by bone stimulation devices in bone fracture treatment

Restraints

• Limited medical reimbursement for bone stimulation products
• High treatment costs associated with BMP and PRP products

Opportunity

• Emerging markets

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=82341383

The Major Objectives of the study:

• To define, describe, and forecast the global Bone Growth Stimulator Market on the basis of product, application, and end user
• To provide detailed information regarding major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To provide market size for various segments of the Bone Growth Stimulator Market with respect to four main geographies, namely, North America (U.S. and Canada), Europe (Germany, France, the U.K., and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and Rest of the World

Browse and in-depth TOC on “Bone Growth Stimulator Market”

66 — Tables

67 — Figures

153 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/bone-growth-stimulator-market-82341383.html

Major Market Developments:

• In 2017, Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim. These devices are used to stimulate and enhance natural healing process of the body post spinal fusion operation.
• In 2016, Bioventus LLC, launched its Ultrasound Bone Healing System, EXOGEN in Saudi Arabia. The product is used in the treatment of delayed unions, non-unions, and joint fusion

The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. North America is expected to dominate the market in 2016. Asia is expected to grow at a highest CAGR during the forecast period. Factors such as large population base, improving healthcare infrastructure and the rising prevalence of obesity and spinal disorders are key factors driving market growth in the Asia-Pacific region.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsample.asp?id=82341383

Orthofix International N.V. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), DJO Finance LLC (U.S.), Bioventus LLC (U.S.), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), and Harvest Technologies Corporation (U.S.) are some of the players operating the Bone Growth Stimulator Market.

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com